Ginkgo biloba extract for mild cognitive impairment
Part of Brain & nervous system, Mental health clinical trials.
This trial tests whether a specific ginkgo biloba extract (EGb761) can improve thinking and memory in people with mild cognitive impairment (MCI). It also looks at changes in blood markers related to the condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with mild cognitive impairment (MCI).
- Your MoCA score is between 19 and 25.
- You can still manage your daily activities (like cooking, shopping, and handling finances) on your own.
- You do not have other serious medical conditions such as active cancer or severe heart/lung disease.
- You are not allergic to any ingredient in the study medication.
- You are able to understand and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an oral supplement called gamma glutamylcysteine (GGC) in people with mild cognitive impairment (MCI) to see if it is safe and well-tolerated. It may help by supporting the body's natural defenses against cell damage.
This trial tests if a supplement called genistein can help people with mild memory problems caused by early Alzheimer's disease. You must have a brain scan showing amyloid buildup and be otherwise healthy enough to participate.
This study tests a new drug, QLH2405, for people with mild cognitive impairment or mild Alzheimer's disease. It aims to see if the drug is safe and how it affects memory and thinking.
This trial tests whether a natural extract from ginkgo biloba can help people with mild memory or thinking problems caused by small vessel disease in the brain. It looks for adults aged 50 to 75 who have had these symptoms for at least 3 months but can still live independently.
This study tests whether Ginkgo biloba extract can improve blood markers and cognitive function in people with mild cognitive impairment (early memory loss). Researchers will measure changes in blood biomarkers to understand how Ginkgo may help protect brain health.
This trial tests whether adding ginkgo biloba extract tablets to standard stroke care helps improve memory and thinking in people who had a mild stroke. You may join if you are 55 or older, had a mild stroke in the last 1 to 2 weeks, and now have some cognitive difficulties.
Hear when a new Alzheimer Disease (AD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.